Pharmaniaga inks local manufacturing deal with Sinovac Biotech


A health worker shows a vial of Sinovac Biotech’s Coronavac during the vaccination of Philippine military at the national headquarters of the Philippine Army in Fort Bonifacio, Taguig City, Metro Manila, Philippines, on Tuesday (March 2, 2021). - Reuters

KUALA LUMPUR: Pharmaniaga Bhd has signed a local manufacturing agreement with China's Sinovac Biotech Ltd's subsidiary for the purchase of ready-to-fill bulk product of Covid-19 vaccine.

The company said on Monday its unit Pharmaniaga Lifescience Sdn Bhd (PLS) and Sinovac Life Sciences Co. Ltd had entered into the agreement on March 12 for the manufacturing of the vaccine by PLS.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Malaysia-Brazil partnership instrumental to Yinson's success
Ringgit advances as domestic optimism offsets US rate concerns
Foreign investors record RM259.8mil weekly net outflow from Bursa Malaysia
Bursa Malaysia stays firmly below 1,600 amid weak regional sentiment
Trading ideas: MAHB, Sime Darby, Pantech, Barakah, Meta Bright, Mudajaya, Citaglobal, Cropmate, Sunsuria
MR DIY’s earnings to pick up in the fourth quarter
AI likely to add US$79bil to Vietnam’s economy by 2030
Boon or bane?
Fed refuses to back Basel climate plan, leaving talks in limbo
MAKING RE CERTIFICATION VIABLE FOR MALAYSIA, REGION

Others Also Read